BlackRock Institutional Trust’s Sonoma Pharmaceuticals SNOA Stock Holding History

BlackRock Institutional Trust’s Portfolio SNOA Stock Details SNOA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$129K	Hold	142	–	–	﹤0.01%	3628
2016 Q3	$111K	Hold	142	–	–	﹤0.01%	3691
2016 Q2	$102K	Hold	142	–	–	﹤0.01%	3705
2016 Q1	$122K	Hold	142	–	–	﹤0.01%	3689
2015 Q4	$147K	Hold	142	–	–	﹤0.01%	3698
2015 Q3	$165K	Hold	142	–	–	﹤0.01%	3665
2015 Q2	$182K	Buy	+142	New	+$133K	﹤0.01%	3644
2014 Q1	–	Sell	-75	Closed	-$236K	–	4018
2013 Q4	$236K	Sell	75 -59	-44%	-$157K	﹤0.01%	3695
2013 Q3	$330K	Hold	134	–	–	﹤0.01%	3598
2013 Q2	$311K	Buy	+134	New	+$479K	﹤0.01%	3571

Other funds holding SNOA

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

AIM

Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Institutional Trust's SNOA Position: Q4 2016 in Review

BlackRock Institutional Trust held its Sonoma Pharmaceuticals (SNOA) position steady in Q4 2016 at 142 shares worth $129K. The position accounts for ﹤0.01% of the portfolio, ranked #3628.

BlackRock Institutional Trust first reported a position in SNOA in Q2 2013 and has held it in 10 quarters since. The position peaked at $330K in Q3 2013. 21 funds tracked by Wall St. Rank hold SNOA as of Q4 2016.

BlackRock Institutional Trust held 142 shares of Sonoma Pharmaceuticals worth $129K as of Q4 2016.
BlackRock Institutional Trust left its Sonoma Pharmaceuticals share count unchanged in Q4 2016.
Sonoma Pharmaceuticals made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3628 holding.
BlackRock Institutional Trust first reported a position in Sonoma Pharmaceuticals in Q2 2013 and has held it in 10 quarters since.
BlackRock Institutional Trust's Sonoma Pharmaceuticals position peaked at $330K in Q3 2013.
21 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.